ROG.SW (ROG.SW) Competitors & Peers
Companies tied to ROG.SW through its disclosed supply-chain and competitive relationships. Numbers are code-computed, never estimated.
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- REGNPartner
Regeneron partnered with Roche to manufacture, develop, and distribute Ronapreve globally.
Model-inferred, unverified — treat as a lead, not evidence - NVOCompetitor
Through its acquisition of Carmot Therapeutics, Roche is developing oral and injectable incretin therapies targeting obesity.
Model-inferred, unverified — treat as a lead, not evidence - LLYCompetitor
Roche's entry into the GLP-1/GIP space makes them a direct competitor to Eli Lilly's Mounjaro and Zepbound.
Model-inferred, unverified — treat as a lead, not evidence